drugset
Drugs / Live Attenuated Mumps Vaccine (Human Diploid Cell)
last change Jul 2024 re-read 3 minutes ago

Live Attenuated Mumps Vaccine (Human Diploid Cell)

also known as Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17)

Vaccine

Developed for
mumps infectious disease
Investigated by
Hubei Provincial Center for Disease Control and Prevention · Institute of Medical Biology, Chinese Academy of Medical Sciences

Trials 1

today NCT03133923 · Ph 2
2018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03133923 May → Nov 2017 mumps infectious disease Institute of Medical Biology, Chinese Academy of Medical Sciences Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Live Attenuated Mumps Vaccine (Human Diploid Cell) ClinicalTrials.gov intervention name — accepted as the source's own label NCT03133923 ↗
Known as Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) “Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in 360 infants(aged 8-24 months ) on 0 day” NCT03133923 ↗
Modality Vaccine “Live Attenuated Mumps (F-genotype) Vaccine” NCT03133923 ↗